THE HOSPITAL FOR SICK CHILDREN

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 54201
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 23102
 
  
 
C07K PEPTIDES 19117
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 16224
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 12155
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 10196
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 990
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 590
 
  
 
A61H PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY 531
 
  
 
C07J STEROIDS514

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0327,789 Modulation of Dopamine Receptor to Promote Neural Cell DifferentiationNov 13, 15Nov 16, 17[A61K, C12N, C07D]
2017/0312,274 METHOD FOR TREATING A BRAIN TUMOURNov 13, 15Nov 02, 17[A61K]
2017/0306,406 DNA METHYLATION MARKERS FOR NEURODEVELOPMENTAL SYNDROMESOct 21, 15Oct 26, 17[C12Q]
2017/0298,437 METHODS AND USES RELATED TO RHABDOID TUMORSAug 17, 16Oct 19, 17[A61K, C12Q]
2017/0242,022 METHODS OF DIAGNOSING AND TREATING COMPLICATIONS OF PREGNANCYSep 28, 16Aug 24, 17[G01N]
2017/0226,570 DNA METHYLATION MARKERS FOR OVERGROWTH SYNDROMESAug 28, 15Aug 10, 17[C12Q]
2017/0216,410 SOLUBLE BACTERIAL AND FUNGAL PROTEINS AND METHODS AND USES THEREOF IN INHIBITING AND DISPERSING BIOFILMJun 05, 15Aug 03, 17[A61K, A01N, A61L]
2017/0058,046 ERBB2 SIGNALING AND NERVE REGENERATIONMay 04, 15Mar 02, 17[C07K]
2016/0303,071 SODIUM ASCORBATE STIMULATION OF ELASTOGENESISJun 28, 16Oct 20, 16[A61K, A61Q]
2016/0220,599 NOVEL LINCRNA AND INTERFERING NUCLEIC ACID MOLECULES, COMPOSITIONS AND METHODS AND USES THEREOF FOR REGULATING ANGIOGENESIS AND RELATED CONDITIONSSep 26, 14Aug 04, 16[A61K, C12N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9908853 Inhibitors of peptidyl arginine deiminase (PAD) enzymes and uses thereofAug 01, 13Mar 06, 18[C07D]
9901612 Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteinsJun 19, 14Feb 27, 18[A61K]
9896732 Method of diagnosing cancer comprising detection of the methylation signature in the hTERT promoterMay 24, 13Feb 20, 18[C12Q]
9867804 Sodium ascorbate stimulation of elastogenesisJun 28, 16Jan 16, 18[A61K, A61Q]
9700593 Methods and uses of slit for treating fibrosisJun 04, 14Jul 11, 17[A61K, C07K]
9605314 MECP2E1 geneDec 09, 13Mar 28, 17[A61K, C12Q, G01N, C07K]
9566263 Methods and formulations for treating scars and β-catenin-mediated disordersDec 19, 14Feb 14, 17[A61K]
9568484 MECP2E1 geneNov 18, 08Feb 14, 17[A61K, C12Q, G01N, C07K]
9548003 System, method and computer program for training for medical examinations involving body parts with concealed anatomyApr 20, 12Jan 17, 17[G09B]
9492462 Composition for elastin productionJun 21, 13Nov 15, 16[A61K, C07K, C07J]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0152,564 MECP2E1 GENEAbandonedFeb 09, 17Jun 01, 17[A61K, C12Q]
2017/0137,887 MECP2E1 GENEAbandonedJan 31, 17May 18, 17[C12Q]
2016/0235,866 MRI CONTRAST AGENTS FOR CELL LABELINGAbandonedOct 06, 14Aug 18, 16[A61K, C07F, G01N]
2016/0157,703 TISSUE GRIPPING DEVICEAbandonedJun 18, 14Jun 09, 16[A61B]
2015/0359,854 INSULIN RECEPTOR INDUCED ELASTIN PRODUCTIONAbandonedJun 08, 15Dec 17, 15[A61K]
2015/0202,185 COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERSAbandonedApr 01, 15Jul 23, 15[A61K]
2015/0041,615 EXTRA CORPOREAL LIFE SUPPORT LEVELLING PLATFORMAbandonedMar 11, 13Feb 12, 15[A61B, A61M]
2015/0044,193 COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED a-SYNUCLEIN FUNCTIONAbandonedJun 16, 14Feb 12, 15[A61K]
2014/0242,095 ANTIBODIES AND ANTIBODY FRAGMENTS TARGETING SIRP-ALPHA AND THEIR USE IN TREATING HEMATOLOGIC CANCERSAbandonedOct 19, 12Aug 28, 14[C07K]
2014/0234,271 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODSAbandonedMay 05, 14Aug 21, 14[A61K, G01N, A61Q]
2014/0142,382 FOLDING ENDOSCOPE AND METHOD OF USING THE SAMEAbandonedDec 09, 13May 22, 14[A61B]
2014/0065,635 PROGNOSTIC TESTS FOR DEVELOPMENT OF DERMAL STRETCH MARKS AND IMPLICATIONS FOR THE PREVENTATIVE TREATMENT THEREOFAbandonedJul 30, 13Mar 06, 14[G01N]
2013/0317,581 METHODS AND DEVICES RELATING TO NON-INVASIVE ELECTRICAL NERVE STIMULATIONAbandonedDec 22, 11Nov 28, 13[A61N]
2013/0274,132 Genetic Modifiers of Cystic FibrosisAbandonedSep 30, 11Oct 17, 13[C12Q]
2013/0210,657 Method of Determining Risk of Autism Spectrum DisorderAbandonedJan 25, 13Aug 15, 13[C12Q]
2013/0203,081 TUMOR CELL-DERIVED MICROVESICLESAbandonedApr 13, 11Aug 08, 13[G01N]
2013/0189,253 MODULATION OF SIRP-ALPHA - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFORAbandonedOct 30, 12Jul 25, 13[A61K]
2013/0184,199 INSULIN RECEPTOR INDUCED ELASTIN PRODUCTIONAbandonedJan 07, 13Jul 18, 13[A61K]
2013/0065,835 PROGNOSTIC TESTS FOR DEVELOPMENT OF DERMAL STRETCH MARKS AND IMPLICATIONS FOR THE PREVENTATIVE TREATMENT THEREOFAbandonedNov 07, 12Mar 14, 13[A61K, C12Q, G01N, A61P]
2013/0060,158 METHODS BASED ON FLUCTUATIONS IN CORTICAL SYNCHRONIZATIONAbandonedNov 02, 12Mar 07, 13[A61B]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.